Related Experiment Video
Updated: Jun 7, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
531
CRISPRoffT: comprehensive database of CRISPR/Cas off-targets
Grant Wang1, Xiaona Liu1, Aoqi Wang2
1Center for Computational Systems Medicine, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, 7000 Fannin St, Houston, TX 77030, USA.
Nucleic Acids Research
|November 11, 2024
Summary
CRISPRoffT is a new database that consolidates off-target gene editing effects from numerous studies. This resource aids in improving CRISPR therapy safety and prediction accuracy.
Area of Science:
- Molecular Biology
- Genetics
- Bioinformatics
Background:
- CRISPR-Cas gene editing offers therapeutic potential but faces challenges with off-target effects.
- Improving the safety and accuracy of CRISPR technologies is crucial for clinical translation.
Purpose of the Study:
- To develop CRISPRoffT, a comprehensive repository of predicted and validated CRISPR off-target regions.
- To facilitate the development of safer gene-editing therapies and enhance prediction algorithms.
Main Methods:
- Integrated off-target analysis data from 74 studies.
- Included 29 experimental prediction techniques, 368 guide sequences, and 8840 validated off-targets.
- Covered various CRISPR approaches (knockout, base editing, prime editing) across 34 cell lines and 85 Cas/gRNA combinations.
Main Results:
- CRISPRoffT provides a unified resource for off-target data from diverse experimental conditions.
- The database enables comparative analyses across guide sequences, genes, cell types, and techniques.
- Offers insights into off-target profiles for different CRISPR editing systems.
Conclusions:
- CRISPRoffT is a valuable resource for safety-driven design of CRISPR therapeutics.
- It supports the advancement of computational off-target prediction and guide RNA design algorithms.
- Facilitates informed experimental design in gene editing research.
Related Concept Videos
CRISPR and crRNAs
16.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.8K
CRISPR
49.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.5K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K

